GESTIÓN EN SALUD PÚBLICA: Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products | FDA

miércoles, 1 de febrero de 2023

Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products | FDA

Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)